BELIDE: Better Living With Non-memory-led Dementia
Launched by UNIVERSITY COLLEGE, LONDON · Jan 26, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The BELIDE trial is studying a new educational program designed to support caregivers of individuals with non-memory led forms of dementia, such as atypical Alzheimer’s disease or frontotemporal dementia. The aim is to see if this program can help improve the mental well-being of caregivers by providing them with tailored information and skills specific to these types of dementia. Many caregivers face unique challenges, especially when caring for someone who may still be in the workforce or has young children, so the program hopes to fill a gap in existing support.
To participate in this trial, caregivers must be at least 18 years old, provide care for someone diagnosed with non-memory led dementia (like primary progressive aphasia or behavioral variant frontotemporal dementia), and have regular contact with the person they're caring for. Participants will engage in an 8-week program that includes online learning modules and support sessions, with follow-ups to discuss their experiences. This trial aims not only to evaluate the program's effectiveness but also to understand how it can be best implemented and what benefits it brings to caregivers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults (18+) who self-identify as an unpaid carer (partners, children, friends, etc.) of someone with PPA, PCA or bvFTD who is not living in a full-time care facility.
- • 2. The care recipient must have a confirmed diagnosis of dementia (through self-report of the carer, to reflect the 'real world' application of the intervention).
- • 3. Able to give informed consent.
- • 4. Good comprehension of written English.
- • 5. Access to the internet.
- Exclusion Criteria:
- • 1. Carers of people living with dementia in full-time care facility.
- • 2. Carers of people with severe dementia in terms of large impact on activities of daily living.
- • 3. Carers of individuals with any form of dementia other than PPA, PCA, or bvFTD. -
About University College, London
University College London (UCL) is a leading global research institution renowned for its commitment to advancing healthcare through innovative clinical trials. As a prominent sponsor of clinical research, UCL leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous investigations aimed at improving patient outcomes and addressing pressing medical challenges. The institution fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring that its trials adhere to the highest ethical standards and regulatory guidelines. UCL's dedication to translating scientific discoveries into practical applications underscores its role as a vital contributor to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported